Suppr超能文献

两性霉素 B 联合选定的 1,3,4-噻二唑衍生物处理的人肾细胞中的氧化还原稳态。

Redox homeostasis in human renal cells that had been treated with amphotericin B in combination with selected 1,3,4-thiadiazole derivatives.

机构信息

Department of Nutrigenomics, and Bromatology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 40-055, Poland.

Department of Molecular Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 40-055, Poland.

出版信息

Pharmacol Rep. 2024 Jun;76(3):557-571. doi: 10.1007/s43440-024-00592-7. Epub 2024 Apr 8.

Abstract

BACKGROUND

The use of amphotericin B (AmB) in the therapy of systemic mycosis is associated with strong side effects, including nephrotoxicity, and hepatotoxicity. Therefore, agents that can reduce the toxic effects of AmB while acting synergistically as antifungal agents are currently being sought. 1,3,4-thiadiazole derivatives are promising compounds that have an antifungal activity and act synergically with AmB. Such combinations might allow the dose of AmB, which is essential for preventing patients from having serious side effects, to be decreased. This might result from the antioxidant properties of 1,3,4-thiadiazoles. Thus, the aim of the study was to investigate redox homeostasis in human renal proximal tubule epithelial cells (RPTEC) after they had been treated with AmB in combination with 1,3,4-thiadiazole derivatives.

METHODS

Cellular redox homeostasis was assessed by investigating the total antioxidant capacity (TAC) of cells, the malondialdehyde (MDA) concentration, and the activity of antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GPX), and catalase (CAT). TAC was measured using an ABTS method. The MDA concentration, and the activity of SOD, GPX, and CAT were determined spectrophotometrically using commercially available assays. Additionally, the antioxidant defense system-related gene expression profile was determined using oligonucleotide microarrays (HG-U133A 2.0). Quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to confirm the microarray results.

RESULTS

Amphotericin B and selected 1,3,4-thiadiazole derivatives had a significant effect on the total antioxidant capacity of the RPTEC cells, and the activity of the antioxidant enzymes. We also revealed that the effect of thiadiazoles on the SOD and CAT activities is dependent on the treatment of RPTEC cells with AmB. At the transcriptional level, the expression of several genes was affected by the studied compounds and their combinations.

CONCLUSIONS

The results confirmed that thiadiazoles can stimulate the RPTEC cells to defend against the oxidative stress that is generated by AmB. In addition, together with the previously demonstrated synergistic antifungal activity, and low nephrotoxicity, these compounds have the potential to be used in new therapeutic strategies in the treatment of fungal infections.

摘要

背景

两性霉素 B(AmB)在系统性真菌感染治疗中的应用与强烈的副作用有关,包括肾毒性和肝毒性。因此,目前正在寻找可以降低 AmB 毒性作用并协同发挥抗真菌作用的药物。1,3,4-噻二唑衍生物是一种有前途的化合物,具有抗真菌活性,并与 AmB 协同作用。这种组合可能会降低预防患者出现严重副作用所需的 AmB 剂量。这可能是由于 1,3,4-噻二唑的抗氧化特性。因此,本研究的目的是研究 AmB 联合 1,3,4-噻二唑衍生物处理人肾近端小管上皮细胞(RPTEC)后细胞内氧化还原稳态。

方法

通过研究细胞总抗氧化能力(TAC)、丙二醛(MDA)浓度以及超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPX)和过氧化氢酶(CAT)等抗氧化酶的活性来评估细胞内氧化还原稳态。TAC 采用 ABTS 法测定。MDA 浓度以及 SOD、GPX 和 CAT 的活性均采用市售试剂盒分光光度法测定。此外,采用寡核苷酸微阵列(HG-U133A 2.0)测定抗氧化防御系统相关基因表达谱。采用定量逆转录聚合酶链反应(RT-qPCR)对微阵列结果进行验证。

结果

两性霉素 B 和选定的 1,3,4-噻二唑衍生物对 RPTEC 细胞的总抗氧化能力和抗氧化酶活性有显著影响。我们还发现,噻二唑类药物对 SOD 和 CAT 活性的影响取决于 RPTEC 细胞中 AmB 的处理。在转录水平上,几种基因的表达受到研究化合物及其组合的影响。

结论

研究结果证实,噻二唑类化合物可刺激 RPTEC 细胞抵抗由 AmB 产生的氧化应激。此外,这些化合物除了先前证明的协同抗真菌活性和低肾毒性外,还有可能用于治疗真菌感染的新治疗策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验